Avedro is developing Keraflex™, an incision-less vision correction procedure enabled by advanced proprietary technology. Keraflex, which uses focused energy to gently reshape the front surface of the cornea, will represent a unique offering in vision correction as it does not require the creation of a flap in the cornea, the removal of any corneal tissue, or any incision. The company initiated its first clinical trials in Q109, and anticipates product launch in Europe in H209.

FlagshipGeneral Partner Doug Cole is on the Board of Directors

www.avedro.com